Showa Medical University Hospital

Shinagawaku, Tokyo 142-86666

2 studies enrolling now · 4 studies all time

What they study most

Atopic Dermatitis, HR+/HER2- Breast Cancer, Hormone Receptor Positive Breast Cancer, Immunoglobulin A Nephropathy (IgAN), Non-small Cell Lung Cancer, Triple Negative Breast Cancer

Studies at this site

• BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease — Recruiting now
• A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) — Recruiting now
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01) — Running, not enrolling